Abstract
Historically, the overall 5-year survival probability from lung cancer is dismal. However, this poor prognosis is not uniformly distributed among those affected—certain subsets of patients appear to fare worse, either due to a more advanced stage at presentation or barriers to appropriate and timely care. Disparities in lung cancer development, diagnosis, treatment, and outcomes are predominantly seen in members of racial, ethnic, and other minority groups, women, HIV patients, and the elderly. The basis for such differences is complex and multifactorial, involving social inequities overlapping with genetic and biologic factors. For this reason, improvement in lung cancer survival can only occur when these disparities are addressed and corrected.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
